SuperCable vs. Conventional Steel Wire for Closure After a Median Sternotomy (SURE)

University of Zurich (UZH)

Status: Not yet enrolling

Conditions: Sternotomy

Treatments: Device: Steel Wires; Device: SuperCable®

Study type: Interventional

Funder types: Other

Identifiers

NCT07251881

2025-D0040

HumRes67145 (Other Identifier)

Details and patient eligibility

About

During certain heart surgeries, the sternum is opened and must then be closed securely. The study compares two closure methods - steel wires and SuperCable - in terms of stability, healing, and patient satisfaction. This investigation aims to demonstrate that the iso-elastic properties of the SuperCable Sternal Closure System result in faster sternal bone healing, reduced postoperative pain, shorter hospital stay, and improved physical recovery compared to conventional steel wire sternal closure. Eighty-six patients are participating and are randomly assigned to one of the two groups. After the operation, pain, healing, and possible complications are checked. The patients are examined 3 and 6 months after the operation.

Enrollment: 86 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of Informed Consent: The subject must have signed and dated the informed consent form prior to any study-related procedures.

• Willingness and Ability to Comply: The subject must express a stated willingness to comply with all study procedures and be available for the duration of the study.

• Age and Sex:

  • Age: The subject must be at least 18 years old.
  • Sex: Both male and female subjects are eligible. In line with the "Sex and Gender in Research Involving Humans" recommendations, data will be stratified and analyzed by sex to identify any potential differences in outcomes.

• Language Competence: The subject must possess sufficient German language skills to accurately complete the postoperative survey

• Travel Capability: The subject must have the ability to travel for all planned study visits, including scheduled CT scans

• Surgical Procedure: The subject must be scheduled for elective coronary artery bypass graft (CABG) procedures, as this is the focus of the investigation

• Adherence to Visit Schedule: The subject must be willing to adhere to all scheduled visits and undergo CT scans as outlined in the study protocol

Exclusion criteria

• Pharmacological Restrictions: Current use of corticosteroids or any immunosuppressive medication

• Prior Treatments and Therapies: History of radiation therapy to the thorax

• Reproductive Considerations:

  • Pregnancy, or the intent to become pregnant during the study period
  • Lactation or current breastfeeding

• Allergic Reactions: Known allergic reactions to components of the conventional steel wire or SuperCable, specifically any known metal allergies (e.g., nickel or titanium).

Example: Patients with a documented history of nickel allergy, including previous adverse reactions to products such as sternal cerclages, will be excluded

• Infectious or Febrile Conditions: Any febrile illness occurring immediately before the scheduled surgery

• Concurrent Investigational Treatments: Treatment with another investigational drug or medical device within two months preceding surgery, as well as during the current investigation

• Surgical History: Subjects who have undergone prior sternotomy and osteosynthesis (i.e., re-do patients) will be excluded

• Anatomical Considerations:

  • Known sternal deformities that could compromise the outcome of the investigation
  • Off-midline sternotomy approaches, as these do not align with the surgical technique under investigation

• Patient Residence and Follow-Up Feasibility: Subjects residing in remote regions, including those from interstate or overseas, where follow-up and adherence to the scheduled visits might be compromised

• Other Specific Exclusions: Any additional criteria specific to the disease under investigation or identified by the investigator based on medical judgment (e.g., clinically significant concomitant disease states such as renal failure, hepatic dysfunction, or cardiovascular disease, if these conditions are deemed to interfere with study outcomes)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

86 participants in 2 patient groups

SuperCable®

Experimental group

Description:

In the intervention group, sternal closure is performed using the SuperCable® Sternotomy Closure System.

Treatment:

Device: SuperCable®

Steel wires

Active Comparator group

Description:

In the control group, sternal closure is performed using conventional USP 7 (United States Pharmacopeia size-designation system) tool steel wires.

Treatment:

Device: Steel Wires